Articles By Jack Cush, MD
RheumNow Week in Review – 5 August 2016
Highlights from this week on RheumNow.com include: 1. Having #RA in addition to solid cancer (breast, lung, prostate, colon) increases mortality rates by 40-50% in elders https://t.co/aitjusmOai 2. The global market for rheumatoid arthritis therapies was $19.9 billion in 2015, expected to reach $21.3B by 2020 https://t.co/d2Sh5C8y9f 3. Half of doctors never heard of MACRA:Medicare Access & CHIP Reauthorization Act. Starts on Jan 1st! https://t.co/eYgWBWCw6y Blog:https://t.co/sRKZSOFyNV And more!
Read Article
Serious Infections are Not Increased in HIV Patients Treated with TNF Inhibitors
Infections are a concern for many when using tumor necrosis factor-α inhibitor (TNFi) therapy to treat inflammatory disorders. Even moreso in those at higher risk.
Read Article
Dinosaur Arthritis
The recent edition of Science has an interesting article on the cause of death in a dinosaur - septic arthritis.Palentologists have unearthed a 70 million year old duck-billed dinosaur near New Jersey and found that the arm bones were not quite right.
Read Article
RAPID3: An Effective Assessment Tool in Spondyloarthritis
Serial biomarker or clinical metric assessments are ubiquitous and commonly used to assess patients with rheumatoid arthritis (HAQ, CDAI, RAPID3), lupus (C3, C4, dsDNA) and gout (uric acid). But numerous disorders are either harder to assess or have tools or metrics that that are not commonly used.
Read Article
Problems with Red Flags in Diagnosing Low Back Pain
There is considerable heterogeneity in "red flags" amongst numerous low back pain (LBP) guidelines worldwide. A "red flags" denotes a finding, which if present, imparts a significantly high risk of underlying serious spinal pathology with considerable subsequent morbidity or mortality.
Read Article
Biosimilars are Bioequivalent to Original TNF Inhibitors
Chingcuanco and coinvestigators have reported on their comparative analysis of biosimilars and their originator TNF inhibitors in the current issue of Annals of Internal Medicine. (Citation source: http://buff.ly/2arTd1q)
Read Article
My Nurse Practitioner
My NP is not only a great nurse, counselor, rheumatologist, complex disease manager, joint injector, diabetes expert, clinic leader, mother, wife, and friend – she’s the go to person if you’re a patient, coworker, colleague, cousin or neighbor. She is one of few great partnerships in my entire career. To go to battle with a NP at my side gives me a tremendous daily advantage.
Read Article
Meniscal Tears May Not Need Surgery
A study published in the British Medical Journal examines whether knee surgery or conservative medical management benefits those with degenerative meniscal tears. (Citation source http://buff.ly/2awVbKu)
Read Article
RheumNow Week in Review - 29 July 2016
Dr Jack Cush reviews this week's highlights from RheumNow.com.
Read Article
Long-Term Safety of Adalimumab Reviewed
Burmester and colleagues have published their review of the long-term outcomes and safety issues with the TNF inhibitor, adalimumab (ADA). The analysis included 15,132 patients exposed to adalimumab in global RA clinical trials.
Read Article
